Drug General Information
Drug ID	D0F2YC
Former ID	DNC014575
Drug Name	1,3-Dibenzyl-[1,3]diazetidine-2,4-dione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526092]
Structure		Download 2D MOL 3D MOL
Formula	C16H14N2O2
Canonical SMILES	C1=CC=C(C=C1)CN2C(=O)N(C2=O)CC3=CC=CC=C3
InChI	1S/C16H14N2O2/c19-15-17(11-13-7-3-1-4-8-13)16(20)18(15)12-14-9-5-2-6-10-14/h1-10H,11-12H2
InChIKey	PGIXYPNBNAOYHW-UHFFFAOYSA-N
PubChem Compound ID	10038543
Target and Pathway
Target(s)	Trypsin	Target Info	Inhibitor	[526092]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Pancreatic secretion
	Protein digestion and absorption
	Influenza A
Reactome	Activation of Matrix Metalloproteinases
	Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways	Activation of Matrix Metalloproteinases
References
Ref 526092	Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.
Ref 526092	Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.